SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-211372
Filing Date
2020-08-06
Accepted
2020-08-06 08:14:52
Documents
3
Period of Report
2020-08-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d56920d8k.htm 8-K 16935
2 EX-99.1 d56920dex991.htm EX-99.1 53096
3 GRAPHIC g56920g34x76.jpg GRAPHIC 3260
  Complete submission text file 0001193125-20-211372.txt   75812
Mailing Address 100 TECHNOLOGY SQUARE 5TH FLOOR CAMBRIDGE MA 02139
Business Address 100 TECHNOLOGY SQUARE 5TH FLOOR CAMBRIDGE MA 02139 857-201-2700
Magenta Therapeutics, Inc. (Filer) CIK: 0001690585 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38541 | Film No.: 201079941
SIC: 2834 Pharmaceutical Preparations